Abeona Therapeutics Inc. (NASDAQ: ABEO)
$5.37
-0.1400 ( -2.54% ) 475.2K
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Market Data
Open
$5.37
Previous close
$5.51
Volume
475.2K
Market cap
$220.79M
Day range
$5.31 - $5.74
52 week range
$2.83 - $9.01
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 74 | Aug 08, 2023 |
8-k | 8K-related | 14 | Aug 08, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |
3 | Insider transactions | 1 | Jul 10, 2023 |
3 | Insider transactions | 1 | Jul 10, 2023 |
8-k | 8K-related | 14 | Jul 07, 2023 |
8-k | 8K-related | 14 | Jul 07, 2023 |
s-3 | Registration statements | Jul 16, 2024 | |
sc | Insider transactions | Jul 16, 2024 |